Dynavax Technologies' (DVAX) shareholder Deep Track Capital has sent a public letter to the company's board regarding the activist investor's four director nominations at the company's upcoming shareholder meeting, Deep Track said Monday.
Deep Track said in the letter that it has received support from a number of "significant" Dynavax holders on its recommended course of action for the biopharmaceutical company, but was disappointed that the board appeared "uninterested in reaching a constructive resolution" with the investment firm.
Dynavax did not immediately respond to a request for comment from MT Newswires.
Price: 14.45, Change: +0.05, Percent Change: +0.35
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.